Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

PURPOSE: The cloned enzyme donor immunoassay (CEDIA) for buprenorphine is applied for both urine drugs-of-abuse screening and compliance monitoring. Sensitivity, specificity, and optimal cutoff of this assay have differed between studies. This may indicate that cross-reactivity has to be taken into...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Jon Andsnes, Schjøtt, Jan, Fossan, Kjell O, Riedel, Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630205/
https://www.ncbi.nlm.nih.gov/pubmed/26604854
http://dx.doi.org/10.2147/SAR.S88935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630205/
https://www.ncbi.nlm.nih.gov/pubmed/26604854
http://dx.doi.org/10.2147/SAR.S88935

Ejemplares similares